Gene Mutation Determines Patient Response to AML

November 12, 2010 | Findings published in the New England Journal of Medicine pinpoint a gene with multiple mutations that seems to determine patient response to acute myeloid leukemia (AML). By comparing the normal and cancer cell genomes of a woman who died of AML, researchers at Washington University identified DNMT3A. Med Page Today